• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    The subject of the present invention is a curable silicone composition comprising a system for temporary inhibition of the irradiation-activated hydrosilylation reaction comprising at least one inhibitor chosen from α-acetylenic alcohols, α-α'-acetylenic diesters, conjugated enene compounds, α-acetylenic ketones, acrylonitriles, maleates, fumarates and mixtures thereof, at least one photoinitiator, and tris (trimethylsilyl) silane (TTMSS). The invention relates to a process for preparing a silicone coating and hard elastomeric materials with said silicone composition.
    公开号:FR3015508A1
    申请号:FR1363276
    申请日:2013-12-20
    公开日:2015-06-26
    发明作者:Emmanuel Pouget；Guillaume Pibre；Sebastien Marrot
    申请人:Bluestar Silicones France SAS；
    IPC主号:
    专利说明:

    [0001] TECHNICAL FIELD OF THE INVENTION The present invention is in the technical field of the preparation of silicone compositions. More specifically, the present invention relates to curable silicone compositions comprising a novel system for inhibiting hydrosilylation reactions.
    [0002] BACKGROUND In the field of silicones, hydrosilylation, also called polyaddition, is a major reaction. In a hydrosilylation reaction, a compound comprising at least one unsaturation reacts with a compound comprising at least one hydrogen atom bonded to a silicon atom. This reaction may for example be described by the reaction equation (1) in the case of an alkene unsaturation: I / II / -Si-H + C = C-Si-C-CH (1) I / Or by the reaction equation (2) in the case of an alkyne unsaturation: I-Si-H + -CC- -Si-C = CH (2) IIII The hydrosilylation therefore allows a on the other hand to form silicone networks by crosslinking between polysiloxanes comprising Si-H units and polysiloxanes comprising Si-vinyl units. A typical application of this reaction is the formation of non-stick silicone coatings or films on paper or polymer supports.
    [0003] The hydrosilylation reactions are conventionally carried out by catalysis. Typically, the suitable catalyst for this reaction is a platinum catalyst, such as, for example, chloroplatinic acid hexahydrate or Karstedt catalyst which consists of platinum complexes with divinyltetramethyldisiloxane as a ligand (see for example in US Patent 3,775). 452). In small quantities, this catalyst makes it possible to carry out hydrosilylation reactions at room temperature with rapid kinetics, of the order of a few minutes. In order to have time to prepare, transport and implement the composition prior to curing, it is often necessary to temporarily inhibit the hydrosilylation reaction. For example, when it is desired to coat a paper or polymer substrate with a non-stick silicone coating, the silicone composition is formulated to form a bath which must remain liquid at room temperature for several hours before being deposited on the substrate. It is only after this deposition that it is desired that the hardening by hydrosilylation occurs. Inhibitors of hydrosilylation reaction can be of several kinds. The most common are thermal inhibitors. Maintained at room temperature, they inhibit the hydrosilylation reaction.
    [0004] By raising the temperature of the reaction medium, the inhibition is deactivated and the hydrosilylation reaction is activated. Conventionally, the thermal activation is carried out by introducing the substrates coated with the curable silicone composition into coating furnaces whose temperature is maintained between 100 ° C. and 150 ° C. Examples of thermal inhibitors and their use are described in patent applications WO 2011/076710, WO 2012/085364 and WO2012 / 175825. The major disadvantage of thermal activation of hydrosilylation is that it can not be used on a non-heat resistant substrate. To solve this problem, it has been proposed to implement hydrosilylation reactions that can be triggered by exposure to UV radiation. For this, one solution is to have a specific hydrosilylation catalyst activatable by UV radiation, as described for example in the international patent application WO 92/10529. Another solution consists in using a conventional hydrosilylation catalyst and adding a photoinhibitor to it: the function of the photoinhibitor is to prevent the hydrosilylation reaction when it is present in the reaction medium. On the other hand, unlike the thermal inhibitor, a photoinhibitor is deactivated not by heat but by exposure to UV radiation.
    [0005] Examples of photoinhibitors have been given in the literature. US Patents 4,640,939 and 4,670,531 describe the use of azo compounds as a reaction inhibitor. EP 0 238 033 discloses photocurable polyorganosiloxane compositions containing an essentially linear diorganopolysiloxane comprising end-chain vinyl functional groups, an organohydrogenpolysiloxane, a platinum-based catalyst, a photosensitizer and optionally a modulator compound which Its function is to avoid the premature reaction of curable compositions. The modulators described are acetylenic compounds such as 3,5-dimethyl-1-hexyn-3-ol, 3-methyl-1-butyn-3-ol, 3-methyl-3-penten-1-yne, 3-methyl-1-pentyn-3-ol and 5,5-dimethyl-3-hexen-1-yne. Furthermore, US Pat. No. 5,082,871 describes the use of compounds of the dialkyl acetylenedicarboxylate type as an inhibitor of the platinum catalyzed hydrosilylation reaction which can be deactivated by UV irradiation. One of the essential functions of an inhibition system is therefore to effectively prevent the hydrosilylation reaction for as long as necessary before activation. For this purpose, it may be necessary to use large quantities of inhibiting agent, which causes a strong inhibition of the hydrosilylation catalyst. This has the consequence that the rate of hardening of the composition, even after activation, is slowed down, which is a major disadvantage from an industrial point of view since this notably obliges to reduce the coating speed and therefore the rate of production. . It would therefore be advantageous to have new hydrosilylation inhibition systems that can be deactivated thermally or by UV irradiation. It is desired to have hydrosilylation-curable silicone compositions containing an inhibition system making it possible both to: - inhibit the hydrosilylation reaction for as long as necessary before activation, - to ensure a rapid lifting of the inhibition at the time of The invention relates to a curable silicone composition comprising: A. at least one organopolysiloxane comprising, per molecule, at least two alkenyl radicals bonded to silicon atoms; B. at least one organohydrogenpolysiloxane comprising, per molecule, at least two hydrogen atoms bonded to silicon atoms, and preferably at least three hydrogen atoms bonded to silicon atoms; C. at least one hydrosilylation catalyst; D. at least one inhibitor selected from α-acetylenic alcohols, acetylenic diesters, en-ene conjugated compounds, α-acetylenic ketones, acrylonitriles, maleates, fumarates and mixtures thereof, minus one photoinitiator, F. tris (trimethylsilyl) silane (TTMSS). The inventors have discovered that, quite surprisingly, the mixture of an inhibitor, a photoinitiator and TTMSS as described above works synergistically and makes it possible to ensure a good inhibition of the hydrosilylation reaction. while having an improved inhibition lifting kinetics compared to known compositions. The subject of the present invention is therefore also the use of a mixture of an inhibitor chosen from α-acetylenic alcohols, α-α'-acetylenic diesters, enne-γne conjugated compounds, α-acetylenic ketones, acrylonitriles, maleates, fumarates and mixtures thereof, a photoinitiator and TTMSS as an inhibition system in a curable silicone composition. This curable silicone composition is particularly suitable for the preparation of silicone coatings, and more particularly for the preparation of non-stick silicone coatings. Therefore, the present invention also provides a process for preparing a silicone coating on a substrate comprising the steps of coating said substrate with said curable silicone composition and curing said composition by irradiation.
    [0006] Furthermore, this curable silicone composition can also be used for the preparation of hard elastomeric materials.
    [0007] BRIEF DESCRIPTION OF THE FIGURES FIG. 1 represents the experimental device used in the examples. Figure 2 shows the evolution of the voltage across the oscillating needle as a function of time during tests 2 to 6 described in the examples.
    [0008] DETAILED DESCRIPTION OF THE INVENTION It is understood that in the context of this description, the term "between ... and" should be interpreted to include the indicated boundaries. The present invention therefore relates to a curable silicone composition comprising A. at least one organopolysiloxane comprising, per molecule, at least two alkenyl radicals bonded to silicon atoms; B. at least one organohydrogenpolysiloxane comprising, per molecule, at least two hydrogen atoms bonded to silicon atoms; and preferably at least three hydrogen atoms bonded to silicon C atoms; at least one hydrosilylation catalyst; D. at least one inhibitor selected from α-acetylenic alcohols, α'-acetylenic diesters, en-ene conjugated compounds, α-acetylenic ketones, acrylonitriles, maleates, fumarates and mixtures thereof, E. at least one photoinitiator, F. tris (trimethylsilyl) silane (TTMSS). The combination of compounds D, E and F is capable of temporarily inhibiting a hydrosilylation reaction between compounds A and compounds B in the presence of the hydrosilylation catalyst C. On the one hand, the composition according to the invention comprises at least one inhibitor D selected from α-acetylenic alcohols, α-α'-acetylenic diesters, ene-yne conjugated compounds, α-acetylenic ketones, acrylonitriles, maleates, fumarates and mixtures thereof . These compounds capable of fulfilling the function of hydrosilylation inhibitor are well known to those skilled in the art. They can be used alone or in mixtures.
    [0009] An inhibitor D of α-acetylenic alcohol type may be chosen from the compounds of formula (D 1) below: (R 1) (R 2) C (OH) -CCH (D 1) in which: the group R 1 represents an alkyl group, a cycloalkyl group, a (cycloalkyl) alkyl group, an aryl group or an arylalkyl group, the R2 group represents a hydrogen atom, an alkyl group, a cycloalkyl group, a (cycloalkyl) alkyl group, an aryl group or a group arylalkyl, or R 1 and R 2 together with the carbon atom to which they are attached a 5-, 6-, 7- or 8-membered aliphatic ring, optionally substituted one or more times. By "alkyl" is meant according to the invention a saturated hydrocarbon chain containing 1 to 20 carbon atoms, preferably 1 to 8 carbon atoms. An alkyl group may be selected from the group consisting of methyl, ethyl, isopropyl, n-propyl, tert-butyl, isobutyl, n-butyl, n-pentyl, isoamyl and 1,1-dimethylpropyl. By "cycloalkyl" is meant according to the invention a monocyclic or polycyclic saturated hydrocarbon group, preferably monocyclic or bicyclic, containing from 3 to 20 carbon atoms, preferably from 5 to 8 carbon atoms. When the cycloalkyl group is polycyclic, the multiple ring nuclei may be attached to each other by a covalent bond and / or by a spinan atom and / or be condensed to each other. Cycloalkyl may be selected from the group consisting of cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, adamantane and norborane.
    [0010] By "(cycloalkyl) alkyl" is meant according to the invention a cycloalkyl group as defined above bonded to an alkyl group as defined above also. By "aryl" is meant according to the invention an aromatic hydrocarbon group containing from 5 to 18 carbon atoms, monocyclic or polycyclic. An aryl group may be selected from the group consisting of phenyl, naphthyl, anthracenyl and phenanthryl.
    [0011] By "arylalkyl" is meant according to the invention an aryl group as defined above bonded to an alkyl group as defined above also. According to a preferred embodiment, R 1 and R 2 together with the carbon atom to which they are attached form an unsubstituted aliphatic ring with 5, 6, 7 or 8 members.
    [0012] According to another preferred embodiment, R 1 and R 2, which are identical or different, represent independently of each other a monovalent C 1 to C 2, preferably C 1 to C 6, alkyl group. An inhibitor D which is an α-acetylenic alcohol useful according to the invention may be selected from the group consisting of the following compounds: 1-ethynyl-1-cyclopentanol; 1- ethynyl-1-cyclohexyl ol (also called ECH); 1-ethynyl-1-cycloheptan ol; 1-ethynyl-1-cyclopropanol; 3-methyl-1-butyn-3-ol (also called MB T); 3-methyl-1-pentyn-3-ol; 3-methyl-1-hexyn-3-ol; 3-methyl-1-heptyn-3-ol; 3-methyl-1-octyn-3-ol; 3-methyl-1-nonyn-3-ol; 3-methyl-1-decyn-3-ol; 3-methyl-1-dodecyn-3-ol; 3-methyl-1-pentadecyn-3-ol; 3-ethyl-1-p-entyn-3-ol; 3-ethyl-1-hexyn-3-ol; 3-ethyl-1-heptyn-3-ol; 3,5-dimethyl-1-hexyn-3-ol; 3-i sobuty1-5-methyl-1-hexyn-3-ol; 3,4,4-trimethyl-1-pentyn-3-ol; 3-ethyl-5-methyl-1-heptyn-3-ol; 3,6-diethyl-1-nonyn-3-ol; 3,7, 1 1-trimethyl-1-dodecyn-3-ol (also called TMDDO); 1,1-diphenyl-2-propyn-1-ol; 3-butyn-2-ol; 1-p entyn-3-ol; 1-hexyn-3-ol; 1-heptyn-3-ol; 5-methyl-1-hexyn-3-ol; 4-ethyl-1-octyn-3-ol and 9-ethynyl-9-fluorenol.
    [0013] An inhibitor D of the α-α'-acetylenic diester type can be chosen from compounds of the following formula (D 2): ## STR5 ## in which the groups R 3 and R 4, which are identical or different, represent independently from each other an alkyl group, a cycloalkyl group, a (cycloalkyl) alkyl group, an aryl group, an arylalkyl group or a silyl group. According to the invention, the term "silyl" means a group of formula -SiR3, each R representing independently an alkyl group containing from 1 to 20 carbon atoms, preferably from 1 to 8 carbon atoms. A silyl group may be, for example, the trimethylsilyl group.
    [0014] According to a particular embodiment, R3 and R4, which may be identical or different, represent, independently of one another, a C1-C12 alkyl group, preferably a C1-C6 alkyl group, or the trimethylsilyl group. An inhibitor D which is an α-α'-acetylenic diester useful according to the invention may be chosen from the group consisting of the following compounds: dimethyl acetylene dicarboxylate (DMAD), diethyl acetylene dicarboxylate, tert-butyl acetylene dicarboxylate and bis (trimethylsilyl) acetylene dicarboxylate. An inhibitor D of the ene-ene conjugated compound type may be chosen from compounds of the following formula (D3): R5 HC R7 R6 (D3) in which: the groups R5, R6 and R7 represent, independently of each other, an atom hydrogen, an alkyl group, a cycloalkyl group, a (cycloalkyl) alkyl group, an aryl group or an arylalkyl group, or at least two of the groups R5, R6 and R7 together with the at least one carbon atom to which they are bound a 5-, 6-, 7- or 8-membered aliphatic ring, optionally substituted one or more times. According to one particular embodiment, the groups R5, R6 and R7 represent, independently of each other, a hydrogen atom, a C1-C12 alkyl group, preferably a C1-C6 alkyl group, or an aryl group. An inhibitor D which is a conjugated ene-yne compound useful according to the invention may be chosen from the group consisting of the following compounds: 3-methyl-3-pentene-1-yne; 3-methyl-3-hexene-1-yne; 2,5-dimethyl-3-hexene-1-yne; 3-ethyl-3-butene-1-yne; and 3-phenyl-3-butene-1-yne.
    [0015] According to another particular embodiment, two groups selected from the groups R5, R6 and R7 together with the carbon atom or atoms to which they are attached form an unsubstituted aliphatic ring with 5, 6, 7 or 8 members and the third group remainder represents a hydrogen atom or a C 1 to C 12 alkyl, preferably a C 1 to C 6 alkyl group. An inhibitor D which is a conjugated ene-yne compound useful according to the invention may be 1-ethynyl-1-cyclohexene. A C1-acetylenic ketone inhibitor D can be chosen from the compounds of formula (D4) below: ## STR2 ## in which R8 represents an alkyl group, a cycloalkyl group, a (cycloalkyl) alkyl group, an aryl group, or an arylalkyl group, the alkyl, cycloalkyl, (cycloalkyl) alkyl, aryl or arylalkyl groups possibly being substituted one or more times by a chlorine, bromine or iodine atom.
    [0016] According to a preferred embodiment, R 8 represents a monovalent C 1 to C 12, preferably C 1 to C 6, alkyl, which may be substituted one or more times by a chlorine or bromine atom, or a cycloalkyl group, or an aryl group. . An inhibitor D which is a cetacetylene ketone useful according to the invention may be selected from the group consisting of the following compounds: 1-octyn-3-one, 8-chloro-1-octyn-3-one; 8-bromo-1-octyn-3-one; 4,4-dimethyl-1-octyn-3-one; 7-chloro-1-heptyn-3-one; 1-hexyn-3-one; 1-pentyn-3-one; 4-methyl-1-pentyn-3-one; 4,4-dimethyl-1-pentyn-3-one; 1-cyclohexyl-1-propyn-3-one; benzoacetylene and o-chlorobenzoyl acetylene. An acrylonitrile inhibitor D may be chosen from compounds of the following formula (D5): (R5) in which R9 and R19 represent, independently of each other, a hydrogen atom, a chlorine atom, bromine or iodine, an alkyl group, a cycloalkyl group, a (cycloalkyl) alkyl group, an aryl group or an arylalkyl group, the alkyl, cycloalkyl, (cycloalkyl) alkyl, aryl or arylalkyl groups possibly being substituted with one or several times by an atom of chlorine, bromine or iodine. An inhibitor D which is a useful acrylonitrile according to the invention may be selected from the group consisting of the following compounds: acrylonitrile; methacrylonitrile; 2-chloroacrylonitrile; crotononitrile and cinnamonitrile. A maleate or fumarate inhibitor D may be chosen from the following compounds of formulas (D6) and (D7): ## STR3 ## in which Rn and R12, which may be identical or different, independently of one another represent an alkyl or alkenyl group, a cycloalkyl group, a (cycloalkyl) alkyl group, an aryl group or an arylalkyl group, said alkyl, alkenyl, cycloalkyl, (cycloalkyl) alkyl, aryl and arylalkyl groups; may be substituted with an alkoxy group. According to the invention, the term "alkenyl" is intended to mean a saturated hydrocarbon-based chain containing from 1 to 20 carbon atoms, preferably from 1 to 8 carbon atoms, comprising at least one double unsaturation. An alkenyl group may be selected from the group consisting of vinyl or allyl. By "alkoxy" is meant according to the invention an alkyl group as defined above bonded to an oxygen atom. An alkoxy group may be selected from the group consisting of methoxy, ethoxy, propoxy and butoxy. According to a particular embodiment, Rn and R12, which may be identical or different, represent, independently of one another, a C1 to C12 alkyl or alkenyl group, preferably a C1 to C6 alkyl group, optionally substituted by a lower alkoxy group. C1 to C6. An inhibitor D which is a maleate or fumarate useful according to the invention may be chosen from the group consisting of diethyl fumarate, diethyl maleate, diallyl fumarate, diallyl maleate and bis (methoxyisopropyl) maleate. ).
    [0017] Inhibitors D selected from α-acetylenic alcohols, α-α'-acetylenic diesters, en-ene conjugated compounds, α-acetylenic ketones, acrylonitriles, maleates, fumarates are commercially available. These include ECH which is commercially available from BASF, dimethyl maleate which is commercially available from DMS and dimethyl acetylene dicarboxylate which is available from City Chemical LLC.
    [0018] In addition to the inhibitor compound D, the composition according to the invention comprises at least one photoinitiator E. A photoinitiator is a chemical compound or a combination of several chemical compounds (in this case we can speak of a photoinitiator system) capable of generating free radicals by radiation absorption having a wavelength between 200 nm and 800 nm. It is possible to use in combination with a photoinitiator a photosensitizer compound. The photosensitizer compounds are well known to those skilled in the art. These are molecules capable of absorbing radiation and transferring this energy to another molecule, in this case the photoinitiator. Photoinitiator compounds are well known to those skilled in the art. They can be used alone or in mixtures. Classically, photoinitiators are classified into two broad categories according to their priming mechanism: type I photoinitiators and type II photoinitiators. Type I photoinitiators are characterized in that the compounds undergo a homolytic cleavage of a bond generating radicals capable of initiating the photopolymerization reaction. Type I photoinitiators may for example be selected from the group consisting of: benzoin and benzoin ethers: benzoin methyl ether, benzoin butyl ether; acetophenones: eg unsubstituted acetophenone, 3-methylacetophonone, 4-methylacetophonone, 3-pentylacetophonone, 4-methoxyacetophonone, 3-bromoacetophonone, 4-allyl acetophonone; alpha-hydroxy ketones, and in particular alpha-hydroxy-acetophenones: for example bis [4- (2-hydroxy-2-methylpropionyl) phenyl] methane, 2-hydroxy-1- [4-4- (2 hydroxy-2-methyl-propionyl) phenoxy) -phenyl] -2-methyl-1-one, 2-hydroxy-2-methyl-1-phenyl-propan-1-one, 2-hydroxy-2-methyl 1- (4-tert-butyl) phenylpropan-1-one; acylphosphine oxides.
    [0019] Type II photoinitiators are characterized by the fact that they do not undergo a fragmentation reaction when, after irradiation, they pass into their excited state (called a "triplet"). Thus, irradiation causes a hydrogen transfer reaction or electron transfer followed by a proton transfer between the photoinitiator and a co-initiator. Type II photoinitiators may be selected from the group consisting of: benzophenones: for example unsubstituted benzophenone, 3-methoxybenzophenone, 4-methoxy-benzophenone, 4-methyl-benzophenone, 4-chlorobenzophenone, 4,4'-dimethoxybenzophenone, 4-chloro-4'-benzylbenzophenone, 2,4,6-trimethylbenzophenone; thioxanthones: for example isopropylthioxanthone; camphorquinone. The co-initiators may be chosen from the group consisting of ethers, amides, amines, thiols, thioethers, sulphates, carboxinates and aliphatic alcohols, and preferably from the following compounds: N-phenylglycine, ethyl p-dimethylaminobenzoate, phenyltetrazolethiol, 2-mercaptobenzothiazol and mixtures thereof. A large number of photoinitiators are commercially available. These include: as a type I photoinitiator: those marketed for example by the companies IGM Resins, Lambson, BASF, Lamberti and Chivacure, for example the Omnirad 102 photoinitiator of IGM Resins, the Irgacure® 184, 1173, 2959 photoinitiators, MBF, 754, 651, 369, 907, 1300, TPO, 819, 2100 and 784 from BASF, and Lamberti Esacure® KIP100F and KIP150 photoinitiators; as type II photoinitiator: Lamberti's Esacure® TZT photoinitiator, BASF's Irgacure® BP photoinitiator, Omnirad CTX, DETX and ITX photoinitiators from IGM Resins, Lamberti's Esacure® EDB co-initiator. According to a preferred embodiment, the composition according to the invention comprises at least one type I photoinitiator, and more preferably at least one alphahydroxyacetophenone.
    [0020] According to another preferred embodiment, the composition according to the invention comprises at least one type II photoinitiator, and more preferably at least one benzophenone or a mixture of several benzophenones.
    [0021] Finally, the composition according to the invention comprises tris (trimethylsilyl) silane F. This chemical compound of formula (CH3Si) 3SiH is commonly called "TTMSS". It is commercially available, for example at Aldrich. The molar ratios between the inhibitor D, the photoinitiator E and the TTMSS are preferably such that: the molar ratio between the TTMSS and the inhibitor D is between 0.0001 and 20, more preferably between 0.001 and 5, and even more preferably between 0.001 and 3; and / or the molar ratio between the TTMSS and the photoinitiator E is between 0.001 and 10, more preferably between 0.005 and 5, and even more preferably between 0.01 and 2. The inventors have discovered that the inhibitor D, photoinitiator E and TTMSS F as described above could advantageously be used as an inhibition system in polyaddition-curable silicone compositions. Surprisingly, it has been discovered that the presence of these three compounds produces a synergistic effect: the inhibition system obtained advantageously makes it possible to ensure good inhibition of the hydrosilylation reaction while having a kinetics of emergence. improved inhibition compared to known compositions. The silicone composition according to the invention is curable. It is able to crosslink by hydrosilylation when exposed to an irradiation source or heat source. It is a silicone composition curable by polyaddition reactions. Preferably, the polyorganosiloxane A according to the invention carries at least two alkenyl groups bonded to silicon atoms. According to a preferred embodiment, this polyorganosiloxane A comprises: (i) at least two units of formula (A1): embedded image in which: Y represents a monovalent radical containing from 1 to 2 (Y); at 12 carbon atoms, having at least one alkene function and optionally at least one heteroatom, - Z represents a monovalent radical containing from 1 to 20 carbon atoms and not comprising an alkene or alkyne function; integers having a value of 1, 2 or 3, b being 0, 1 or 2 and (a + b) equal to 1, 2 or 3; (ii) and optionally comprising other units of formula (A2): ZcS10 (4- c) / 2 (A2) in which: Z has the same meaning as above, and c represents an integer from 0 to 3.
    [0022] It is understood in formula (A1) and in formula (A2) above that, if more than one Y and Z radicals are present, they may be the same or different from each other. In formula (A1), the symbol a may preferably be 1 or 2, more preferably 1. Moreover, in formula (A1) and in formula (A2), Z may represent a monovalent radical chosen from the group consisting of an alkyl group having 1 to 8 carbon atoms, optionally substituted with at least one halogen atom, and an aryl group. Z may advantageously represent a monovalent radical selected from the group consisting of methyl, ethyl, propyl, 3,3,3-trifluoropropyl, xylyl, tolyl and phenyl. Furthermore, in formula (A1), Y may advantageously represent a radical selected from the group consisting of vinyl, propenyl, 3-butenyl, 5-hexenyl, 9-decenyl, 10-undecenyl, 5,9-decadienyl and 6, 11-dodecadienyl. The polyorganosiloxane A may have a linear, branched, cyclic or lattice structure. In the case of linear polyorganosiloxanes, these may consist essentially of: siloxyl units "D" chosen from units of formulas Y 2 SiO 2/2, Y 2 SiO 2/2 and Z 2 SiO 2/2; siloxyl units "M" chosen from the units of formulas Y3Si01 / 2, Y2ZSi01 / 2, YZ2Si01 / 2 and Z3S102 / 2.
    [0023] By way of examples of "D" units, mention may be made of dimethylsiloxy, methylphenylsiloxy, methylvinylsiloxy, methylbutenylsiloxy, methylhexenylsiloxy, methyldecenylsiloxy and methyldecadienylsiloxy groups. By way of example of "M" units, mention may be made of trimethylsiloxy, dimethylphenylsiloxy, dimethylvinylsiloxy and dimethylhexenylsiloxy groups. These linear polyorganosiloxanes may be oils having a dynamic viscosity at 25 ° C. of between 1 mPa.s and 100 000 mPa.s, preferably between 10 mPa.s and 5000 mPa.s, or gums having a dynamic viscosity at 25.degree. ° C greater than 100 000 mPa.s.
    [0024] When it is a question of cyclic polyorganosiloxanes, these may consist of "D" siloxyl units chosen from the units of formulas Y 2 SiO 2/2, Y 2 SiO 2/2 and Z 2 SiO 2/2. Examples of such "D" patterns are described above. These cyclic polyorganosiloxanes can have a dynamic viscosity at 25 ° C of between 1 mPa.s and 5000 mPa.s.
    [0025] The dynamic viscosity at 25 ° C. of all the polymers described in the present application can be measured using a Brookfield viscometer. Examples of polyorganosiloxanes A are: polydimethylsiloxanes with dimethylvinylsilyl ends; poly (methylphenylsiloxane-co-dimethylsiloxane) with dimethylvinylsilyl ends; poly (vinylmethylsiloxane-co-dimethylsiloxane) with dimethylvinylsilyl ends; poly (dimethylsiloxane-co-vinylmethylsiloxane) with trimethylsilyl ends; cyclic polymethylvinylsiloxanes. The organohydrogenpolysiloxane B according to the invention carries at least two hydrogen atoms bonded to silicon atoms, and preferably at least three hydrogen atoms bonded to silicon atoms. According to a preferred embodiment, this polyorganosiloxane B comprises: (i) at least two units of formula (B1), and preferably at least three units of formula (B1): HdLeS 10 (4 - (d + e)) / 2 (B1) wherein: - L represents a monovalent radical different from a hydrogen atom, - H represents the hydrogen atom, - d and e represent integers, d being 1 or 2, e being 0 , 1 or 2 and (d + e) being 1, 2 or 3; and optionally other units of formula (B2): LfSiO (44) / 2 (B2) in which: L has the same meaning as above, and f represents an integer between 0 and 3. It is understood in formula (B1) and in formula (B2) above that if several L groups are present, they may be the same or different from each other. In the formula (B1), the symbol d may preferentially be 1.
    [0026] In addition, in the formula (B1) and in the formula (B2), L can represent a monovalent radical chosen from the group consisting of an alkyl group having 1 to 8 carbon atoms, optionally substituted by at least one halogen atom. , and an aryl group. L may advantageously represent a monovalent radical chosen from the group consisting of methyl, ethyl, propyl, 3,3,3-trifluoropropyl, xylyl, tolyl and phenyl.
    [0027] Examples of units of formula (B1) are as follows: H (CH 3) 2 SiO 1/2, HCH 3 SiO 2/2 and H (C 6 H 5) SiO 2/2. The polyorganosiloxane B can have a linear, branched, cyclic or network structure. In the case of linear polyorganosiloxanes, these may essentially consist of: siloxyl units "D" chosen from units of the formulas HLSiO 2/2 and L 2 SiO 2/2; siloxyl units "M" chosen from among the units of formulas HL2Si01 / 2 and L3S102 / 2.
    [0028] These linear polyorganosiloxanes may be oils having a dynamic viscosity at 25 ° C. of between 1 mPa.s and 100 000 mPa.s, preferably between 10 mPa.s and 5000 mPa.s, or gums having a dynamic viscosity at 25.degree. ° C greater than 100 000 mPa.s. In the case of cyclic polyorganosiloxanes, these may consist of "D" siloxyl units chosen from units of formulas HLSiO212 and L2SiO212, or of siloxyl units of formula HLSiO212 only. The units of formula L2SiO212 may especially be dialkylsiloxy or alkylarylsiloxy. These cyclic polyorganosiloxanes can have a dynamic viscosity at 25 ° C of between 1 mPa.s and 5000 mPa.s. Examples of polyorganosiloxanes B are: - polydimethylsiloxanes with hydrogenodimethylsilyl ends; poly (dimethylsiloxane-co-hydrogenomethylsiloxane) with trimethylsilyl ends; poly (dimethylsiloxane-co-hydrogenomethylsiloxane) with hydrogenodimethylsilyl ends; polyhydrogenomethylsiloxanes with trimethylsilyl ends; cyclic hydrogenomethylpolysiloxanes. In the case of branched or networked polyorganosiloxanes, these may furthermore comprise: siloxyl "T" units chosen from the units of formulas HSiO312 and LSiO3 / 2; siloxyl units "Q" of formula SiO4 / 2. Advantageously, the silicone composition according to the invention contains polyorganosiloxane compounds A and organohydrogenpolysiloxane compounds B in proportions such that the molar ratio of the hydrogen atoms bonded to the silicon atoms in the organohydrogenpolysiloxane compound B to the alkenyl groups bonded to atoms of silicon in the polyorganosiloxane compound A is preferably between 0.1 and 10, and more preferably between 0.5 and 5. The silicone composition according to the invention further comprises a hydrosilylation catalyst C. Preferably, it is a platinum compound, for example chloroplatinic acid hexahydrate, the Karstedt catalyst which consists of platinum complexes with divinyltetramethyldisiloxane as a ligand (see for example in US Patent 3,775,452). or a platinum catalyst comprising carbene ligands. Preferably, when the catalyst C comprises platinum, the amount of inhibitor D preferably represents between 10 ppm and 2000 ppm by weight, more preferably between 20 ppm and 1000 ppm by weight, relative to the weight of platinum. . Other auxiliary agents and customary additives may be incorporated into the composition according to the invention. These are chosen according to the applications in which said compositions are used. As families of usual functional additives, mention may be made of: adhesion promoters, such as, for example, organosilicon compounds bearing both one or more hydrolysable groups bonded to the silicon atom, and one or more selected organic groups in the group of (meth) acrylate, epoxy and alkenyl radicals, more preferably still in the group consisting of the following compounds taken alone or as a mixture: vinyltrimethoxysilane (VTMO), 3-glycidoxypropyltrimethoxysilane (GLYMO), methacryloxypropyltrimethoxysilane ( MEMO); fog additives ("anti-misting"), such as silica particles or branched polyorganosiloxanes; - adhesion modulators; additives to increase consistency; antifreeze agents; - wetting agents; anti-foaming agents; - the charges ; the pigments; - bactericides; additives for heat resistance, resistance to oils or fire resistance, for example metal oxides. Quantitatively, the compositions according to the invention may have standard proportions in the technical field considered, knowing that one must also take into account the intended application.
    [0029] The silicone composition according to the invention can be prepared by mixing the various compounds according to the methods known to those skilled in the art. Preferably, the hydrosilylation catalyst is the last compound added to the mixture. It is not excluded in the present invention that the constituents of the inhibition mixture (inhibitor, photoinitiator and TTMSS) are mixed separately and then added to the other constituents of the composition in the form of a ready-to-use additive. The silicone composition according to the invention is particularly suitable for the preparation of silicone coating, and particularly for the preparation of non-stick silicone coating. This coating makes non-adherent supports to surfaces to which they adhere normally. The subject of the present invention is also a process for preparing a non-stick silicone coating on a substrate comprising the steps of coating at least a portion of said substrate with said silicone composition according to the invention, and then curing said composition by irradiation .
    [0030] The support is preferably of flexible material. It may advantageously be chosen from flexible supports made of paper, cardboard or the like, fibrous flexible supports, whether woven or not, and flexible supports made of polymer. Examples of carriers include papers of various types (supercalendré, coated, glassine), cartons, cellulose sheets, plastic films, in particular polyester (for example PET), polyethylene polypropylene or polyvinyl chloride. The composition may be applied using coating devices known to those skilled in the art, in particular using a high-speed industrial coating machine, for example at speeds greater than or equal to 100 m / min, preferably greater than or equal to 300 m / min, and more preferably between 500 m / min and 1000 m / min. These devices comprise a five-roll coating head and air knife or equalizing bar systems, allowing the liquid composition to be deposited on the supports. The amounts of deposited compositions are of the order of 0.1 to 5 g per m 2 of surface to be treated, which corresponds to the deposition of layers of the order of 0.1 to 5 μm in thickness.
    [0031] The support coated with the composition is exposed to radiation whose wavelength is preferably between 200 nm and 800 nm, preferably UV radiation whose wavelength is preferably between 200 nm and 400 nm. UV lamps commonly used are UV mercury vapor lamps (high, low and especially medium pressure). These can be doped with gallium-indium, iron or lead to modify the emission wavelength. The metals contained in these lamps can be excited by electric arc and microwave discharge.
    [0032] Other currently commercially available radiation sources are LEDs with narrow emission spectra over 365 nm, 375 nm, 385 nm, 395 nm, 400 nm and 405 nm, as well as halogen lamps. The heating of the coated support may optionally be carried out at a temperature of at least 40.degree. C., preferably of between 40.degree. C. and 190.degree. C., in order to accelerate the curing of the composition according to the invention.
    [0033] Furthermore, this curable silicone composition can also be used for the preparation of hard elastomeric materials. The process for preparing hard elastomeric materials consists in causing the composition to harden by irradiation and possibly by heating the curable silicone composition. These hard elastomer materials can be prepared and shaped by techniques known to those skilled in the art such as molding or extrusion in a UV chamber. The elastomeric material may have a variable thickness. Preferably, in the present invention, the elastomeric material has a small thickness generally between 0.15 mm and 1 cm, preferably between 1 mm and 1 cm. In the case where the elastomer material has a greater thickness, for example between 1 cm and 10 cm, it is possible to adapt the wavelength of the irradiation so that it penetrates deep into the material. Furthermore, photosensitizer compounds known to those skilled in the art can be added to the silicone composition. This embodiment is particularly suitable for the manufacture of elastomeric tubes, cables or rods, and for the encapsulation ("potting") of electronic components.
    [0034] The inventors have shown that, when the silicone composition according to the invention was subjected to irradiation, the reaction inhibition system was deactivated and the composition was able to harden by the effect of the hydrosilylation reactions. The silicone composition according to the invention has the following advantageous properties: the silicone composition has good storage stability: its pot life, without submitting to irradiation, is greater than 12 hours, preferably greater than 15 hours, at room temperature and above 1 hour at 40 ° C. This shows that the inhibition system is effective. The hydrosilylation reactions are advantageously inhibited for periods of time sufficient to allow the manipulation of the silicone composition on an industrial scale. The inventors have discovered that, very advantageously, the lifting of the inhibition is very rapid. The rate of the lifting of the inhibition which is caused by the irradiation of the silicone compositions can be estimated by measuring the time necessary to observe a beginning of crosslinking of the composition. In addition, the rapid lifting of the inhibition is advantageously accompanied by a good kinetics of crosslinking. The combination of a rapid rise in inhibition with a high crosslinking kinetics makes it possible to achieve low gel times for the compositions. The use of the inhibition system according to the invention makes it possible to reduce the gel time of the composition significantly, without reducing the storage stability of the composition. - The reaction inhibition system allows faster release of inhibition than known inhibitors. Therefore, for an equal irradiation time, the silicone composition according to the invention can be cured in a manner equivalent to known compositions with less catalyst. The composition according to the invention therefore advantageously makes it possible to reduce the amount of hydrosilylation catalyst in the silicone composition without modifying the curing speed. - The curing of the silicone composition is activated by irradiation. This method is easy to implement, and has the advantage of being able to choose the hardening zone, thus allowing to consume less energy than via the thermal methods. Advantageously, the irradiation does not cause excessive heating of the composition and the support on which it has been deposited. Preferably, the composition and its support are subjected to temperatures of less than or equal to 50 ° C, more preferably less than or equal to 40 ° C, and more preferably less than or equal to 35 ° C. These are temperatures significantly lower than the temperatures necessary for curing the silicone compositions thermally, which require the passage in a heated oven at a temperature generally between 70 ° and 200 ° C. The composition according to the invention is therefore particularly useful for the coating of heat-sensitive substrates. - The silicone composition according to the invention can be implemented in ambient atmosphere, which represents a significant industrial advantage over other photocurable silicone compositions. In fact, the radiation-curable silicone compositions conventionally use radical chemical reactions which often require an inert atmosphere, without oxygen. In the present invention, the curing reactions of the silicone composition are not radical reactions but essentially polyaddition reactions. Inerting the means of production is therefore advantageously not necessary. Other objects, features and advantages of the invention will become apparent from the following examples, which are given purely by way of illustration and in no way limitative. EXAMPLES Reagents used: POSvl A: polydimethylsiloxane end-chain vinylated oil of formula M11) 75M "and dynamic viscosity at 25 ° C = 100 mPa.s, with Mvi (CH3) 2 (vinyl) SiO2 / 2 and D = (CH 3) 2 SiO 2 12 POSH B: A trimethylsilyl endblocked polymethylhydrogenosiloxane oil having the average formula M2D'45 and a dynamic viscosity at 25 ° C of 20 mPa.s with M = (CH3) 3SiOii2 and D '= H (CH3) 1SiO2 / 2. Catalyst C: Platinum solution 0 with divinyltetramethyldisiloxane ligands diluted in a silicone oil with an elemental Pt content of 2800 ppm by weight D-1-ethynyl-1-cyclohexanol (ECH) inhibitor, which is an alcohol acetylenic true Photoeminer E: Omnirad 102, sold by the company IGM Resins: 2-hydroxy-2-methyl-1- (4-tert-butyl) phenylpropanone (type I photoinitiator), Esacure® TZT, marketed by the company Lamberti: mixture of 4-methylbenzophenone and 2,4,6-trimethylbenzophenone (typical photoinitiator e II).
    [0035] OH Esacure® TZT Omnirad 102 TTMSS: tris (trimethylsilyl) silane, marketed by Aldrich.
    [0036] Preparation of the silicone compositions: Each formulation was prepared in the proportions indicated in the tables below and in the following way: The inhibitor D was mixed with the POSvi A until total solubilization. POSH B was introduced into the inhibitor mixture D + POSvi A. To this tri-component mixture were optionally added (according to the amounts indicated in the tables) the TTMSS F and a photoinitiator E. Finally, the formulation was completed. with catalyst addition C. Experimental protocol: The duration of the inhibition of the system is measured by monitoring the rheological behavior of the formulation. For this, a device as shown in Figure 1 has been used. This device is provided with a vibrating needle 1 dipping in the formulation studied 2. The frequency of the vibration of the needle is imposed. Before irradiation, the formulation 2 is liquid and the needle 1 vibrates freely. The output voltage followed by a signal processing device 3 is therefore high. At the initial time to, the UV light source 4 was started and this light irradiates the formulation 2 via a mirror 5. When the formulation 2 begins to harden under the effect of crosslinking reactions, oscillation amplitude of the needle 1 is decreased and the output voltage decreases. The beginning of the crosslinking is the time from which the output voltage is no longer constant.
    [0037] The kinetics of crosslinking is evidenced by the slope of the output voltage curve as a function of time.
    [0038] The freezing time of the formulation is defined here as the minimum point of the derivative of the output voltage as a function of time. Prior to the tests carried out on silicone formulations according to the invention, a temperature control in the device was made. The formulation 2 is replaced by a silicone oil. A temperature measuring probe was dipped into the silicone oil. The sample was irradiated for 45 minutes. The maximum temperature reached is 35 ° C. Tests and results: All the tests were carried out under the same conditions (time of introduction of the platinum-based catalyst, time and method of homogenization of the mixture, mixing volume, time between the different additions and setting up irradiation). The formulations were prepared as described above in the proportions indicated in Table 1: Test 1 Test 2 Test 3 Test 4 Comparative Comparative Comparative Test Comparative Invention POS A 3.00 g 3.00 g 3.00 g 3.00 g 3.00 g POSH B 0.21 g 0.21 g 0.21 g 0.21 g 0.21 g Catalyst C 0.11 g 0.11 g 0.11 g 0.11 g 0, 11 g Inhibitor D 2.01 g 2.01 g 2.01 g 2.01 g 2.01 g Photo-initiator E: Omnirad 102 0 0 0 0.0198 g 0.0247 g TTMSS 0 0.0128 g 0.0297 g 0 0.0140 g Molar ratio: Inhibitor D / Catalyst C 15.45 15.63 15.95 14.99 14.66 TTMSS / Inhibitor D 0 2.12 4.93 0 2.32 Photoinitiator E / Inhibitor D 0 0 0 3,70 4,62 TTMSS / - - - 0 0,50 Photo-initiator E Result: Frost time (min): 20,4 18,5 17,4 16,5 11,7 Beginning of 19 17,5 16 Cross-linking (min): Table 1 The power of the mercury lamp was 5.6 W / cm 2. The curves representing the evolution of the output voltage across the oscillating needle as a function of time during tests 1 to 5 are shown in FIG. 2.
    [0039] For a given Inhibitor D / Catalyst C ratio, the TTMSS added without photoinitiator and in large molar excess relative to the inhibitor (TTMSS / D inhibitor molar ratios of 2 to 5) has a positive but limited impact on the onset time of crosslinking and freezing time. (see comparative tests 1, 2 and 3).
    [0040] Under the same conditions, the addition of photoinitiator E without TTMSS (comparative test 4), in a photoeminer E / inhibitor D molar ratio of 3.7, produces a more effective effect on the start time of crosslinking and the freezing time. . Finally, when the photoinitiator E and the TTMSS are added together (test 5 according to the invention), a synergistic effect is observed: the beginning of the crosslinking is observed after 9 minutes and the gel time goes from 20.4 minutes to 11 minutes. 7 minutes (cf comparative test 1 and test according to the invention 5). Other formulations were prepared in the proportions indicated in Table 2: Assay 6 Assay 7 Assay 8 Assay 9 Assay 10 Comparative Comparative Comparative Comparative Comparative Trial 11 POS Assay 3,66.10-3 3,66.10-3 3,66.10 3.66 × 10 -3 3.66 × 10-3 3.66 × 10 -3 (in moles of Si-vinyl functional groups) POSH B 6.12 × 10 -6 6.13 × 10 -6 6.13 × 10 -6 6.13 × 10 -6, 14.10-3 6,12.10-3 (in moles of Si-H functions) Catalyst C 61 61 59 63 64 68 (in ppm of Pt) Inhibitor D 4.65 × 10-s 4.65 × 10-s 4.66 × 10 -s 4, 65.10-s 4.65.10-s 4.65.10-s (in moles) Photoinitiator E: 0 2.31.10-s 9.40.10-6 0 0 9.24.10-6 Omnirad 102 (in moles) TTMSS 0 0 0 9, 53.10-6 2.36.10-5 9.84.10-7 (in moles) Ratio molar: TTMSS / 0 0 0 0.2 0.5 0.02 Inhibitor D Photoinitiator E / Inhibitor D 0 0.5 0.2 0 0 0.2 TTMSS / - 0 0 - - 0.1 Photoinitiator E Result: Gel time 24 16 17 23 22 13 (min): Start of the 21 13 15 20 19 10 crosslinking (min): Pot life (hour): Table 2 The results obtained from The assays described in Table 2 confirm that the presence of TTMSS without the photoinitiator (comparative tests 9 and 10) did not have a significant impact on the beginning of crosslinking and the gel time for TTMSS / D inhibitor molar ratios. the order of 0.2 to 0.5. In these cases, the freezing times are between 22 and 24 minutes. The addition of photoinitiator E (without the addition of TTMSS) has a greater effect. For a photoemorner E / D inhibitor molar ratio of 0.5 (comparative test 7), the gel time is 16 minutes compared with 24 minutes for the reference formulation (comparative test 6).
    [0041] Test 11 (according to the invention) illustrates the beneficial influence of the presence of TTMSS and photoinitiator E. A 45% reduction in gel time is observed with respect to the reference formulation (comparative test 6) and 23% relative to the formulation containing only photoinitiator E (comparative test 8). Other formulations have been prepared in the proportions indicated in the following Table 3 and confirm the advantages of the invention.
    [0042] Assay 12 Assay 13 Assay 14 Assay Assay 15 Assay 18 Assay 18 Assay 18 Comparative Invention Assay POSvl A 3.65.10-s 3.66.10-s 3.66.10-s 3.66.10-s 3.66.10-s 3.66 × 10 -7.58 × 10 -6 moles of Si-vinyl functional groups POSH B 6,12.10-s 6,12,10-s 6,13,10-s 6,13,10-s 6,14,10-s 6,13,10-s s 1.27.10-2 (in moles of Si-H functions) Catalyst C 62 63 62 63 61 62 58 (in ppm of Pt) Inhibitor D 4,65.10-s 4,65.10-s 4,66.10-s 4,65.10 4.66.10-s 4.66.10-s 9.64.10-s (in moles) photoinitiator 0 9.33.10-6 9.34.10-6 9.29.10-6 1.04-4- 9 9.34.10-6 1, 90.10-4 E: Omnirad 102 (in moles) TTMSS 0 1.48.10-7 1.02.10-6 9.44.10-6 1.03.10-6 1.02.10-6 1.87.10-6 (in moles) Ratio molar: TTMSS / 0 0.003 0.02 0.2 0.02 0.02 0.02 Inhibitor D Photo-initiator E / Inhibitor D 0 0.2 0.2 0.2 0.02 0.2 2 TTMSS / - 0.02 0 , 1 1 1 0.1 0.01 Photo-initiator E Result: Freezing time 20 11 13 12 16 13 16 (min): Beginning of the 18 9 10 10 12 10 9 cross-linking (min): Pot life (hour): 22 19 22 19 22 Tabl water 3 (* tests 14 and 17 are identical) Feasibility test with type II photoinitiator E: Several formulations were prepared in the proportions indicated in the following table 4: Test 19 Test 20 Test 21 Test 22 Test 23 Comparative comparison 10 g 10g 10g 10g (4 mmol) (4 mmol) (4 mmol) (4 mmol) POSH B 430 mg 430 mg 430 mg 430 mg 430 mg (6.9 mmol) 6.9 mmol) (6.9 mmol) (6.9 mmol) (6.9 mmol) Catalyst C 100 mg 100 mg 100 mg 100 mg 100 mg (0.0014 (0.0014 (0.0014 (0.O. 0014 (0.0014 mmol) mmol) mmol) mmol) mmol) D-inhibitor 15 mg 15 mg 15 mg 15 mg 15 mg (0.121 mmol) (0.121 mmol) (0.121 mmol) (0.121 mmol) (0.121 mmol) Photo-initiator E: Omnirad 102 0 0 0.023 mmol 0.023 mmol 0 Photoinitiator E: Esacide TZT 0 0 0 0 0.023 mmol TTMSS 0 67 mg 0 67 mg 67 mg (0.270 mmol) (0.270 mmol) (0.270 mmol) Molar ratio: Inhibitor D / Catalyst C 86 86 86 86 86 TTMSS / Inhibitor D 0 2,2 0 2,2 2,2 Photo-initiator E / Inhibiteu r D 0 0 0.19 0.19 0.19 TTMSS / - - 0 11.7 11.7 Photo-initiator E Result: Crosslinking time: 160 min 160 min 160 min 148 min 148 min Table 4 Adding a Type II photoinitiator has the same effect as the addition of a Type I photoinitiator.
    权利要求:
    Claims (10)
    [0001]
    REVENDICATIONS1. A curable silicone composition comprising: A. at least one organopolysiloxane comprising, per molecule, at least two alkenyl radicals bonded to silicon atoms; B. at least one organohydrogenpolysiloxane comprising, per molecule, at least two hydrogen atoms bonded to silicon atoms, and preferably at least three hydrogen atoms bonded to silicon atoms; C. at least one hydrosilylation catalyst; D. at least one inhibitor selected from α-acetylenic alcohols, acetylenic diesters, en-ene conjugated compounds, α-acetylenic ketones, acrylonitriles, maleates, fumarates and mixtures thereof, minus one photoinitiator, F. tris (trimethylsilyl) silane (TTMSS). 15
    [0002]
    2. Composition according to Claim 1, characterized in that the inhibitor D is an inhibitor of the α-acetylenic alcohol type chosen from compounds of the following formula (Dl): (R 1) (R 2) C (OH) -CCH (D) Wherein R 1 is alkyl, cycloalkyl, (cycloalkyl) alkyl, aryl or arylalkyl, R 2 is hydrogen, alkyl, cycloalkyl , a (cycloalkyl) alkyl group, an aryl group or an arylalkyl group, or R 1 and R 2 together with the carbon atom to which they are attached form a 5-, 6-, 7- or 8-membered aliphatic ring, optionally substituted with a or several times. 30
    [0003]
    3. Composition according to claim 1, characterized in that the inhibitor D is an α-α'-acetylenic diester inhibitor chosen from the following compounds of formula (D2): R-O-R4 (D2) wherein the same or different R3 and R4 are independently alkyl, cycloalkyl, (cycloalkyl) alkyl, aryl, arylalkyl or silyl.
    [0004]
    4. Composition according to claim 1, characterized in that the inhibitor D is a maleate or fumarate type inhibitor selected from the following compounds of formulas (D6) and (D7): OR11O OR11 OR12 0 0 12 0 (D6) OR (D7) in which Rn and R12, which may be identical or different, represent, independently of one another, an alkyl or alkenyl group, a cycloalkyl group, a (cycloalkyl) alkyl group, an aryl group or an arylalkyl group, said groups Alkyl, alkenyl, cycloalkyl, (cycloalkyl) alkyl, aryl and arylalkyl groups may be substituted by an alkoxy group.
    [0005]
    5. Composition according to any one of claims 1 to 4, characterized in that it comprises at least one photoinitiator E type I, and more preferably at least one alpha-hydroxy-acetophenone, or at least one photoinitiator E type II, and more preferably at least one benzophenone or a mixture of several benzophenones.
    [0006]
    6. Composition according to any one of claims 1 to 5, characterized in that the molar ratios between the inhibitor D, the photoinitiator E and the TTMSS are such that: the molar ratio between the TTMSS and the inhibitor D is included between 0.0001 and 20, more preferably between 0.001 and 5, and even more preferably between 0.001 and 3; and / or the molar ratio between the TTMSS and the photoinitiator E is between 0.001 and 10, more preferably between 0.005 and 5, and even more preferably between 0.01 and 2.
    [0007]
    7. Composition according to any one of claims 1 to 6, characterized in that, when the catalyst C comprises platinum, the amount of inhibitor D is between 10 ppm and 2000 ppm by weight, more preferably between 20 ppm and 1000 ppm by weight, based on the weight of platinum.
    [0008]
    A process for preparing a silicone coating, preferably a release silicone coating, on a substrate comprising the steps of coating said substrate with the curable silicone composition as defined in any one of claims 1 to 7 and harden this composition by irradiation.
    [0009]
    A process for preparing hard elastomeric materials comprising causing the curable silicone composition as defined in any one of claims 1 to 7 to cure by irradiation and optionally by heating said composition.
    [0010]
    10. Use of a mixture of an inhibitor chosen from α-acetylenic alcohols, α-α'-acetylenic diesters, ene-yne conjugated compounds, α-acetylenic ketones, acrylonitriles, maleates, fumarates and mixtures thereof, a photoinitiator and TTMSS as an inhibition system in a curable silicone composition.
    类似技术:
    公开号 | 公开日 | 专利标题
    EP3083855B1|2018-03-21|New inhibiting system for photoactivable hydrosilylation
    EP0184965B1|1989-01-04|Silicone compositions for antiadherent coating and application process
    JP2500250B2|1996-05-29|Platinum complex and its manufacturing method
    FR2801601A1|2001-06-01|Heat-curable silicone-adhesive complex for use in production of adhesive-protection paper and labels, has adjustable interface release force
    FR2712297A1|1995-05-19|Compositions based on epoxy silicone, curable by UV rays, non-stick.
    EP2176367B1|2018-07-25|Process for reducing the appearance of mist during the coating of flexible supports with a crosslinkable liquid silicone composition in a roll device
    EP2723816A1|2014-04-30|Hydrosilylation reaction inhibitors, and use thereof for preparing stable curable silicone compositions
    EP0146422A1|1985-06-26|Ketone inhibitor for platinum catalysts, and polysiloxane compositionscontaining such an inhibitor
    WO2007068657A1|2007-06-21|Method for controlling onset of fog when coating flexible supports with a liquid silicone composition, in a cylinder-type device
    EP3408340A1|2018-12-05|Use of a type ii photoinitiator system for crosslinking silicone compositions
    WO1995025735A1|1995-09-28|Platinum complexes and light-activatable hydrosilylation catalysts containing same
    FR2717482A1|1995-09-22|Organoplatinic complexes and photoactivatable catalytic hydrosilylation systems containing them.
    EP1501890A1|2005-02-02|Silicone composition which is cross-linkable by dehydrogenization with condensation in the presence of a metallic catalyst
    WO2007065921A1|2007-06-14|Method of preventing the appearance of misting when coating flexible media with a crosslinkable liquid silicone composition in a multi-roll device
    CA2030335C|1996-08-27|Organopolysiloxane composition with a free cyclopentenyl group that can be cross-linked in thin layer by u.v. light
    KR102105781B1|2020-04-28|1-component, storage-stable, UV-crosslinkable organosiloxane composition
    WO2012084992A1|2012-06-28|Silicon composition that is cross-linkable by hydrosilylation, and method for coating or manufacturing objects using said composition
    EP0145526A2|1985-06-19|Allene-inhibiting agent for platinum catalysts, and polysiloxane compositions containing such an inhibitor
    FR2647801A1|1990-12-07|CURABLE COMPOSITION, UNDER RADIATION, BASED ON POLYORGANOSILOXANE WITH PROPANALDEHYDE FUNCTION
    同族专利:
    公开号 | 公开日
    ES2674547T3|2018-07-02|
    JP6234590B2|2017-11-22|
    CN105980498A|2016-09-28|
    EP3083855B1|2018-03-21|
    US9834648B2|2017-12-05|
    KR101791809B1|2017-10-30|
    CN105980498B|2017-10-03|
    US20160319086A1|2016-11-03|
    KR20160102006A|2016-08-26|
    JP2016540868A|2016-12-28|
    EP3083855A1|2016-10-26|
    WO2015090551A1|2015-06-25|
    FR3015508B1|2016-02-05|
    EP3083855B8|2018-06-06|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    EP0238033A2|1986-03-17|1987-09-23|Shin-Etsu Chemical Co., Ltd.|A photocurable organopolysiloxane composition|
    US6046250A|1990-12-13|2000-04-04|3M Innovative Properties Company|Hydrosilation reaction utilizing a free radical photoinitiator|
    US20030027003A1|2000-01-02|2003-02-06|Toru Nakamura|Process film for use in producing ceramic green sheet and method for producing the film|
    US3775452A|1971-04-28|1973-11-27|Gen Electric|Platinum complexes of unsaturated siloxanes and platinum containing organopolysiloxanes|
    FR2571732B1|1984-10-15|1987-01-09|Rhone Poulenc Spec Chim|ORGANOPOLYSILOXANIC COATING COMPOSITION FOR USE IN PARTICULAR FOR NON-STICK TREATMENT AND METHOD OF APPLICATION|
    US4670531A|1986-01-21|1987-06-02|General Electric Company|Inhibited precious metal catalyzed organopolysiloxane compositions|
    US5082871A|1986-12-22|1992-01-21|General Electric Company|UV-activation of addition cure silicon coatings|
    JPH0523304B2|1987-07-07|1993-04-02|Shinetsu Chem Ind Co|
    JP3915872B2|1999-11-04|2007-05-16|信越化学工業株式会社|Method for producing tetrakis silane and tris silane|
    CN101511967B|2006-09-01|2015-11-25|纳幕尔杜邦公司|The phenol stabilizers of fluoroolefins|
    DE102008000156A1|2008-01-25|2009-07-30|Wacker Chemie Ag|Radiation-activated hydrosilylation reactions|
    JP5781536B2|2009-12-23|2015-09-24|ブルースター・シリコーンズ・フランス・エスアエス|Hydrosilylation reaction inhibitors and their use in coating methods|
    BR112013016067A2|2010-12-24|2016-09-20|Bluestar Silicones France|"crosslinkable and / or hardenable composition, silicone composition and elastomer, use of silicone composition, coated solid support and coating process on a flexible support"|
    JP5945593B2|2011-06-21|2016-07-05|ブルースター・シリコーンズ・フランス・エスアエス|Hydrosilylation reaction inhibitors and their use to prepare stable curable silicone compositions|KR20180030070A|2015-07-09|2018-03-21|모멘티브 퍼포먼스 머티리얼즈 인크.|Siloxane crosslinking method using sulfur compound and platinum catalyst|
    FR3045641B1|2015-12-22|2021-04-30|Bluestar Silicones France|USE OF A TYPE II PHOTOINITIATOR SYSTEM FOR CROSS-LINKING SILICONE COMPOSITIONS|
    KR20180034937A|2016-09-28|2018-04-05|모멘티브퍼포먼스머티리얼스코리아 주식회사|Composition for organic electronic device encapsulant and encapsulant manufactured by using the same|
    TW201829672A|2017-02-10|2018-08-16|美商道康寧公司|Curable composition and coated substrate|
    CN109705581B|2018-12-25|2021-07-13|浙江清华柔性电子技术研究院|Silicone rubber composition, silicone rubber and preparation method thereof|
    CN111363199A|2020-03-09|2020-07-03|国科广化新材料研究院有限公司|Silicon dioxide composite material with photoinitiation function and preparation and application thereof|
    WO2021262337A1|2020-06-22|2021-12-30|Dow Silicones Corporation|Low intensity radiation curable silicone release coating composition and method for its preparation and use|
    法律状态:
    2015-11-10| PLFP| Fee payment|Year of fee payment: 3 |
    2017-09-29| ST| Notification of lapse|Effective date: 20170831 |
    优先权:
    申请号 | 申请日 | 专利标题
    FR1363276A|FR3015508B1|2013-12-20|2013-12-20|NEW PHOTOACTIVABLE HYDROSILYLATION INHIBITION SYSTEM|FR1363276A| FR3015508B1|2013-12-20|2013-12-20|NEW PHOTOACTIVABLE HYDROSILYLATION INHIBITION SYSTEM|
    ES14821063.6T| ES2674547T3|2013-12-20|2014-12-15|New photoactivable hydrosilylation inhibition system|
    US15/104,788| US9834648B2|2013-12-20|2014-12-15|Photoactivatable system for inhibiting hydrosilylation|
    JP2016540953A| JP6234590B2|2013-12-20|2014-12-15|A novel photoactivation system for inhibiting hydrosilylation|
    KR1020167019554A| KR101791809B1|2013-12-20|2014-12-15|Novel photoactivatable system for inhibiting hydrosilylation|
    EP14821063.6A| EP3083855B8|2013-12-20|2014-12-15|New inhibiting system for photoactivable hydrosilylation|
    PCT/EP2014/003352| WO2015090551A1|2013-12-20|2014-12-15|Novel photoactivatable system for inhibiting hydrosilylation|
    CN201480075068.4A| CN105980498B|2013-12-20|2014-12-15|Can photoactivation hydrosilylation inhibition system|
    [返回顶部]